Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapy
ConclusionsMPI score is an effective tool for the stratification of older patients with cancer eligible for immunotherapy with checkpoint inhibitors. Further studies are required to achieve conclusive remarks on MPI usefulness in different underlying tumor types.
Source: Journal of Geriatric Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Geriatrics | Immunotherapy | Kidney Cancer | Lung Cancer | Melanoma | Merkel Cell Carcinoma | Non-Small Cell Lung Cancer | Renal Cell Carcinoma | Skin Cancer | Study | Toxicology | Women